Ralf Schirrmacher

5.4k total citations
184 papers, 4.1k citations indexed

About

Ralf Schirrmacher is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Ralf Schirrmacher has authored 184 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Radiology, Nuclear Medicine and Imaging, 61 papers in Molecular Biology and 56 papers in Oncology. Recurrent topics in Ralf Schirrmacher's work include Radiopharmaceutical Chemistry and Applications (74 papers), Medical Imaging Techniques and Applications (46 papers) and Peptidase Inhibition and Analysis (25 papers). Ralf Schirrmacher is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (74 papers), Medical Imaging Techniques and Applications (46 papers) and Peptidase Inhibition and Analysis (25 papers). Ralf Schirrmacher collaborates with scholars based in Germany, Canada and United States. Ralf Schirrmacher's co-authors include Björn Wängler, Carmen Wängler, Esther Schirrmacher, Vadim Bernard‐Gauthier, Klaus Jurkschat, Peter Bartenstein, Alexey Kostikov, Justin J. Bailey, Frank Rösch and Joshua Chin and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Chemistry of Materials.

In The Last Decade

Ralf Schirrmacher

180 papers receiving 4.1k citations

Peers

Countries citing papers authored by Ralf Schirrmacher

Since Specialization

Citations

This map shows the geographic impact of Ralf Schirrmacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Schirrmacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Schirrmacher more than expected).

Fields of papers citing papers by Ralf Schirrmacher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralf Schirrmacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Schirrmacher. The network helps show where Ralf Schirrmacher may publish in the future.

Co-authorship network of co-authors of Ralf Schirrmacher

This figure shows the co-authorship network connecting the top 25 collaborators of Ralf Schirrmacher. A scholar is included among the top collaborators of Ralf Schirrmacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralf Schirrmacher. Ralf Schirrmacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development and clinical potential of ¹⁸F-PSiMA for prostate cancer PET imaging 2025 ·RSC Medicinal Chemistry ·(unknown), Justin J. Bailey, Melinda Wuest, (unknown), Alexey Kostikov, (unknown), Carmen Wängler, Frank Wuest, Ralf Schirrmacher	1
2	Structured reporting of neuroendocrine tumors in PET/CT using [18F]SiTATE - impact on interdisciplinary communication 2025 ·Scientific Reports ·(unknown), (unknown), (unknown), R. Ebner, Nicola Fink, Matthias F. Froelich, Dominik Nörenberg, Carmen Wängler, Björn Wängler, Ralf Schirrmacher, Adrien Holzgreve, Matthias Brendel, Stefanie Corradini, Christoph J. Auernhammer, Johannes Rübenthaler, (unknown)	0
3	PET Imaging in Dementia: Mini-Review and Canadian Perspective for Clinical Use 2024 ·Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques ·Freimut D. Juengling, Frank Wuest, Ralf Schirrmacher, Jonathan Abele, Alexander Thiel, Jean‐Paul Soucy, Richard Camicioli, Valentina Garibotto	4
4	PET/CT imaging of differentiated and medullary thyroid carcinoma using the novel SSTR-targeting peptide [18F]SiTATE – first clinical experiences 2024 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Vera Wenter, Johannes Toms, Simon Lindner, Marcus Unterrainer, (unknown), Klaus Jurkschat, Carmen Wängler, Björn Wängler, Ralf Schirrmacher, (unknown), (unknown), (unknown), Matthias Brendel, Johannes Rübenthaler, Christoph J. Auernhammer, Christine Spitzweg, Lena M. Unterrainer, Adrien Holzgreve	5
5	Ultrasound-Assisted Solid-Phase Affibody Synthesis Using ZEGFR:1907 as an Example—Superior to the Conventional Protocol? 2024 ·Pharmaceuticals ·(unknown), (unknown), (unknown), Björn Wängler, Ralf Schirrmacher, Carmen Wängler	0
6	Are 3D Tumor Cell Spheroids a Utile System for the In Vitro Evaluation of Diagnostic Radiotracers? 2024 ·ACS Omega ·(unknown), (unknown), Björn Wängler, Ralf Schirrmacher, Rüdiger Rudolf, Carmen Wängler	1
7	CycloSiFA: The Next Generation of Silicon‐Based Fluoride Acceptors for Positron Emission Tomography (PET) 2023 ·Angewandte Chemie International Edition ·(unknown), (unknown), (unknown), (unknown), (unknown), Carmen Wängler, Björn Wängler, Klaus Jurkschat, Norbert Krause, Ralf Schirrmacher	3
8	Synthesis, Radiolabeling, and In Vitro and In Vivo Characterization of Heterobivalent Peptidic Agents for Bispecific EGFR and Integrin α_vβ₃ Targeting 2023 ·ACS Omega ·(unknown), (unknown), Xia Cheng, Björn Wängler, Ralf Schirrmacher, Gert Fricker, Carmen Wängler	10
9	Towards Radiolabeled EGFR-Specific Peptides: Alternatives to GE11 2023 ·Pharmaceuticals ·(unknown), Björn Wängler, Ralf Schirrmacher, Gert Fricker, Carmen Wängler	4
10	Toward Optimized 89Zr-Immuno-PET: Side-by-Side Comparison of [89Zr]Zr-DFO-, [89Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [89Zr]Zr-DFO-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable? 2022 ·Pharmaceutics* ·(unknown), Xia Cheng, (unknown), Ralf Schirrmacher, Björn Wängler, Gert Fricker, Carmen Wängler	10
11	Toward the Development of GE11-Based Radioligands for Imaging of Epidermal Growth Factor Receptor-Positive Tumors 2022 ·ACS Omega ·(unknown), (unknown), Ralf Schirrmacher, Björn Wängler, Gert Fricker, Carmen Wängler	4
12	Recent Advances in the Clinical Translation of Silicon Fluoride Acceptor (SiFA) 18F-Radiopharmaceuticals 2021 ·Pharmaceuticals ·(unknown), (unknown), (unknown), (unknown), (unknown), Carmen Wängler, Peter Bartenstein, Leonie Beyer, Simon Lindner, Klaus Jurkschat, Björn Wängler, Justin J. Bailey, Ralf Schirrmacher	17
13	Synthesis and Preclinical Evaluation of [¹⁸F]SiFA-PSMA Inhibitors in a Prostate Cancer Model 2021 ·Journal of Medicinal Chemistry ·Justin J. Bailey, Melinda Wuest, Michael Wagner, Atul Bhardwaj, Carmen Wängler, Björn Wängler, John F. Valliant, Ralf Schirrmacher, Frank Wuest	10
14	Efficient radiosynthesis and preclinical evaluation of [¹⁸F]FOMPyD as a positron emission tomography tracer candidate for TrkB/C receptor imaging 2020 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Thomas A. Singleton, (unknown), Justin J. Bailey, Sangho Choi, (unknown), Pedro Rosa‐Neto, Ralf Schirrmacher, Vadim Bernard‐Gauthier, Alexey Kostikov	9
15	Development and biological evaluation of[18F]FMN3PA & [18F]FMN3PU for leucine-rich repeat kinase 2 (LRRK2) in vivo PET imaging 2020 ·European Journal of Medicinal Chemistry ·Noeen Malik, (unknown), Siobhan McCormick, Nadine Colpo, Helen Merkens, (unknown), François Bénard, Vesna Sossi, Ralf Schirrmacher, Paul Schaffer	8
16	<sup>18</sup>F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor (SiFA) for Positron Emission Tomography 2020 ·Journal of Visualized Experiments ·(unknown), Justin J. Bailey, Harun Ilhan, Peter Bartenstein, Carmen Wängler, Björn Wängler, Melinda Wuest, Frank Wuest, Ralf Schirrmacher	2
17	GlucoSiFA and LactoSiFA: New Types of Carbohydrate-Tagged Silicon-Based Fluoride Acceptors for 18F-Positron Emission Tomography (PET) 2019 ·Synthesis ·(unknown), (unknown), (unknown), (unknown), Ralf Schirrmacher, Klaus Jurkschat, Norbert Krause	1
18	Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 – Part II 2017 ·Expert Opinion on Therapeutic Patents ·Justin J. Bailey, Ralf Schirrmacher, (unknown), Vadim Bernard‐Gauthier	42
19	¹⁸F-Labeled Silicon-Based Fluoride Acceptors: Potential Opportunities for Novel Positron Emitting Radiopharmaceuticals 2014 ·BioMed Research International ·Vadim Bernard‐Gauthier, Carmen Wängler, Esther Schirrmacher, Alexey Kostikov, Klaus Jurkschat, Björn Wängler, Ralf Schirrmacher	34
20	The Temporal Dynamics of Poststroke Neuroinflammation: A Longitudinal Diffusion Tensor Imaging–Guided PET Study with ¹¹C-PK11195 in Acute Subcortical Stroke 2010 ·Journal of Nuclear Medicine ·Alexander Thiel, (unknown), Caroline Paquette, (unknown), Jean‐Paul Soucy, Ralf Schirrmacher, Jeffrey Minuk	121

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact